Ph.D. Candidate in Clinical Investigation
Albert Einstein College of Medicine
Ameya Kulkarni’s research focuses on understanding the mechanisms of human aging and developing biomarkers for interventions that can target aging and extend human healthspan. Using translatable pharmacological interventions like Metformin and Acarbose, he is running proof-of-concept clinical trials in elderly individuals to identify tissue-specific transcriptomic changes relevant to drug action.